Related Experiment Video
Updated: May 6, 2026

High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor
Published on: June 14, 2018
Forty-year Development Alongside Juntendo University's Department of Hematology
Insights
Vitamin D3 may inhibit myeloid leukemia growth, requiring further animal studies. Genetic analysis identified critical deleted regions in chromosome 7 associated with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Bone marrow transplantation is a developing treatment.
- Vitamin D3 shows potential in inhibiting myeloid leukemia.
- Chromosome 7 abnormalities are common in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
Purpose of the Study:
- Investigate the role of tumor suppressor genes in chromosome 7 deletions in AML.
- Analyze the CD4/CD8 T cell ratio and Interleukin-16 (IL-16) levels in multiple myeloma (MM).
Main Methods:
- Identified smallest commonly deleted regions in chromosome 7q.
- Analyzed CD4/CD8 T cell ratios.
- Measured serum IL-16 levels.
Main Results:
- Defined critical deleted regions in chromosome 7 as 7q31.1 and 7q33-34.
- Observed a decreased CD4/CD8 T cell ratio in multiple myeloma patients.
- Found elevated serum IL-16 levels in stage III multiple myeloma patients.
Conclusions:
- Alterations in tumor suppressor genes within 7q31.1 and 7q33-34 are implicated in de novo AML.
- The decreased CD4/CD8 ratio and elevated IL-16 suggest immune dysregulation in multiple myeloma.
Abstract:
After I graduated from Juntendo University in 1985, I joined the Department of Collagen Disease and was assigned to the Hematology Group. At that time, bone marrow transplantation was being developed as a groundbreaking treatment. Juntendo hospitals were also conducting bone marrow transplantation. Vitamin D3 inhibits clonal growth of myeloid leukemia, another cancer, and this finding needs further study in animals before clinical trials can be considered. Loss of a whole chromosome 7 (-7), or the long arm of chromosome 7 del (7q) occurs frequently in myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML). We identified the smallest commonly deleted regions to as 7q31.1 (D7S486) and 7q33-34 (D7S498, D7S505), suggesting that alterations of a tumor suppressor genes in each region play an important role in de novo AML. We found that the ratio of CD4+ to CD8+ T cells (CD4/CD8 ratio) was decreased in patients with multiple myeloma (MM). The serum level of interleukin-16 (IL-16) was significantly higher in stage III patients, which is produced by activated CD8+ T cell and can induce CD4+ T cell activation. I would like to express my deep gratitude to CEO Hideoki Ogawa and the many other people at Juntendo University for giving me the opportunity to work at a university that is experiencing such incredible growth.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hematopoiesis
Regulation of Hematopoietic Stem Cells
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

